Latest News and Press Releases

Applied Biologics expands national commercial payer engagement strategy for XWRAP® to broaden patient access.

Applied Biologics extends longstanding system-wide agreement with Providence Health & Services for XWRAP®.

– Response rates up to 50% across evaluated dose levels and median PFS of 13 months observed in pre-treated, cabozantinib-naïve, locally advanced or metastatic ccRCC patients – – Activity compares...

WASHINGTON, July 21, 2026 (GLOBE NEWSWIRE) -- The Coalition to Improve Access to Cancer Care (CIACC), convened by the International Myeloma Foundation (IMF), applauds Senators Tina Smith (D-MN) and...

Applied Biologics initiates multi-center real-world outcomes study of XWRAP® across chronic wound types.

Applied Biologics announces submission of XWRAP® translational research abstract to SAWC Fall 2026.

WASHINGTON, D.C., July 15, 2026 (GLOBE NEWSWIRE) -- The 4-H Leadership Academy welcomes its second class of Roth Scholars, with 25 young leaders from Alabama, Idaho, Minnesota, New Jersey, and Ohio...

Peninsula Open Space Trust acquires 238-acre San Gregorio Ranch, expanding San Gregorio State Beach by 50% with public access beginning July 29.

Applied Biologics announces manufacture of its first research construct for the preclinical DMOAD Gene Therapy Program.

– Oral presentation will feature updated data from the FIT-001 Phase 1a study of darlifarnib plus cabozantinib in cabozantinib-naïve, advanced ccRCC patients – – Updated data expected to support...